9SSG | pdb_00009ssg

PENICILLIN-BINDING PROTEIN 1B (PBP-1B) in complex with Cephalexin - Streptococcus pneumoniae R6


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.64 Å
  • R-Value Free: 
    0.195 (Depositor), 0.205 (DCC) 
  • R-Value Work: 
    0.171 (Depositor), 0.183 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Structural and Dynamics Analyses of beta-Lactam Inhibition of Streptococcus pneumoniae Penicillin-Binding Protein 1b (PBP1b) Guide Interrogation of Structure-Activity Relationships.

Flanders, P.L.Gillingham, J.R.Contreras-Martel, C.Dessen, A.Carlson, E.E.Ambrose, E.A.

(2026) ACS Chem Biol 

  • DOI: https://doi.org/10.1021/acschembio.5c00788
  • Primary Citation of Related Structures:  
    7ZUH, 9SSD, 9SSE, 9SSF, 9SSG, 9SSH, 9SSI

  • PubMed Abstract: 

    The Gram-positive pathogen Streptococcus pneumoniae , like the majority of bacteria, contains a peptidoglycan-based cell wall whose structure is highly dependent on the action of penicillin-binding proteins (PBPs). While the β-lactam antibiotics have been employed as an antimicrobial strategy for nearly a century, much remains unclear about how inhibitor structure informs potency and PBP isoform selectivity. Here, we obtained high-resolution structures (<2Å) of S. pneumoniae PBP1b cocrystallized with 6 β-lactams. Surprisingly, 2 structures feature a noncanonical conformation of the covalent "acyl-enzyme complex." To clarify how protein-ligand interactions mediate inhibitor binding, we applied molecular modeling and molecular mechanics-based dynamics analyses. Our analyses illustrate how seemingly minimal changes to inhibitor structure modulate β-lactam binding mode and inhibitor potency, as described by the metric k inact / K I . Furthermore, we demonstrate that persistent interaction in the covalent acyl-enzyme complex between the inhibitor carboxylate and a highly conserved three-residue motif is not fully predictive of k inact / K I for PBP1b. In silico modeling suggests that the noncovalent preacyl complex may leverage this interaction, but a postacylation change in ligand conformation may accompany acylation in some inhibitors. The elucidation of key PBP1b ligand-receptor interactions pre- and postacylation will inform the rational design of novel PBP inhibitors and probes.


  • Organizational Affiliation
    • Department of Medicinal Chemistry, University of Minnesota, 208 Harvard Street SE, Minneapolis, Minnesota 55454, United States.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Penicillin-binding protein 1B494Streptococcus pneumoniae R6Mutation(s): 4 
Gene Names: pbp1b
UniProt
Find proteins for O70038 (Streptococcus pneumoniae)
Explore O70038 
Go to UniProtKB:  O70038
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO70038
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1JXD (Subject of Investigation/LOI)
Query on A1JXD

Download Ideal Coordinates CCD File 
B [auth A](2~{R})-2-[(1~{R})-1-[[(2~{R})-2-azanyl-2-phenyl-ethanoyl]amino]-2-oxidanylidene-ethyl]-5-methyl-5,6-dihydro-2~{H}-1,3-thiazine-4-carboxylic acid
C16 H19 N3 O4 S
SGDBJNVCNZNWTA-MSJRJPAQSA-N
SO3 (Subject of Investigation/LOI)
Query on SO3

Download Ideal Coordinates CCD File 
FA [auth A]SULFITE ION
O3 S
LSNNMFCWUKXFEE-UHFFFAOYSA-L
CL (Subject of Investigation/LOI)
Query on CL

Download Ideal Coordinates CCD File 
AA [auth A]
BA [auth A]
C [auth A]
CA [auth A]
D [auth A]
AA [auth A],
BA [auth A],
C [auth A],
CA [auth A],
D [auth A],
DA [auth A],
E [auth A],
EA [auth A],
F [auth A],
G [auth A],
H [auth A],
I [auth A],
J [auth A],
K [auth A],
L [auth A],
M [auth A],
N [auth A],
O [auth A],
P [auth A],
Q [auth A],
R [auth A],
S [auth A],
T [auth A],
U [auth A],
V [auth A],
W [auth A],
X [auth A],
Y [auth A],
Z [auth A]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.64 Å
  • R-Value Free:  0.195 (Depositor), 0.205 (DCC) 
  • R-Value Work:  0.171 (Depositor), 0.183 (DCC) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 96.049α = 90
b = 148.162β = 90
c = 99.185γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
XSCALEdata scaling
PHASERphasing
ARP/wARPmodel building
Cootmodel building
REFMACrefinement

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Agence Nationale de la Recherche (ANR)FranceANR-10-INBS-0005-02
Agence Nationale de la Recherche (ANR)FranceANR-17-EURE-0003
National Institutes of Health/National Cancer Institute (NIH/NCI)United StatesR01 GM128439A1
National Institutes of Health/National Cancer Institute (NIH/NCI)United StatesR35 GM153306
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United States5T32GM132029-5

Revision History  (Full details and data files)

  • Version 1.0: 2026-02-18
    Type: Initial release